JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB59235

Anti-Myosin Phosphatase antibody

Be the first to review this product! Submit a review

|

(11 Publications)

Rabbit Polyclonal Myosin Phosphatase antibody. Suitable for WB, IHC-P and reacts with Mouse, Human samples. Cited in 11 publications. Immunogen corresponding to Synthetic Peptide within Human PPP1R12A.

View Alternative Names

MBS, MYPT1, PPP1R12A, Protein phosphatase 1 regulatory subunit 12A, Myosin phosphatase-targeting subunit 1, Protein phosphatase myosin-binding subunit, Myosin phosphatase target subunit 1

3 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myosin Phosphatase antibody (AB59235)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myosin Phosphatase antibody (AB59235)

ab59235 at 1/50 dilution staining Myosin Phosphatase in human brain by Immunohistochemistry, Paraffin embedded tissue, in the absence or presence of the immunising peptide.

Western blot - Anti-Myosin Phosphatase antibody (AB59235)
  • WB

Unknown

Western blot - Anti-Myosin Phosphatase antibody (AB59235)

All lanes:

Western blot - Anti-Myosin Phosphatase antibody (ab59235) at 1/500 dilution

Lane 1:

NIH3T3 cell extract

Lane 2:

NIH3T3 cell extract with immunising peptide

Predicted band size: 115 kDa

Observed band size: 130 kDa

false

Western blot - Anti-Myosin Phosphatase antibody (AB59235)
  • WB

CiteAb

Western blot - Anti-Myosin Phosphatase antibody (AB59235)

Myosin Phosphatase western blot using anti-Myosin Phosphatase antibody ab59235. Publication image and figure legend from Montalvo, J., Spencer, C., et al., 2013, Curr Mol Med, PubMed 22934846.

ab59235 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab59235 please see the product overview.

ROCK1 & 2 display paralog specific cytoskeletal control in endothelial cells. (A) Growth patterns of confluent monolayers of MS1 endothelial cells stably expressing either non-targeting control, ROCK1, or ROCK2 shRNA expression vectors, or non-targeting control shRNA MS1 cells treated with 10 μM Y27632. (B) MS1 endothelial cells stably expressing non-targeting control, ROCK1, or ROCK2 shRNA expression vectors, and control shRNA MS1 cells treated with 10 μM Y27632 were grown on glass coverslips for 24 hours. Actin microfilaments in each condition were visualized by rhodamine-conjugated phalloidin staining while nuclei were counterstained with DAPI. Immunofluorescent images were captured with scanning confocal microscopy. (solid arrows=areas of cell retraction; a=control shRNA, b=Y27632, c= ROCK1 shRNA, d=ROCK2 shRNA) (C) Semi-quantitative RT-PCR analysis of actin alpha 1 (Acta1), actin alpha 2 (Acta2), and Gapdh steady state mRNA expression levels. (D) Western blot detection of the phosphorylated (p) and total (t) forms of the myosin binding subunit of myosin phosphatase (MBS), cofilin, and ezrin/radixin/moesin (ERM). Ponceau staining of the membrane was used as a loading control. (E) Quantification of the normalized levels of phosphorylated MBS, cofilin, and ERM phosphorylation in each condition. (C=control shRNA, R1=ROCK1 shRNA, R2=ROCK2 shRNA, Y=Y27632; * indicates p<0.05)

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Human

Applications

WB, IHC-P

applications

Immunogen

Synthetic Peptide within Human PPP1R12A. The exact immunogen used to generate this antibody is proprietary information.

O14974

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.87% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Myosin phosphatase sometimes also known as Myosin Light Chain Phosphatase is an enzyme that plays a mechanical role in the dephosphorylation of myosin light chains which are important for muscle contraction and cell motility. This enzyme typically consists of three subunits: a catalytic subunit known as protein phosphatase 1 and two regulatory subunits. Together they generally create a structure with a mass between 100-150 kDa. You will find myosin phosphatase widely expressed across muscle tissues such as cardiac smooth and skeletal muscles.
Biological function summary

Myosin phosphatase regulates contraction by reversing phosphorylation of myosin light chains an important process in muscle function and various cellular activities. This enzyme operates as part of the myosin phosphatase complex where it provides the capability needed to maintain equilibrium between phosphorylating and dephosphorylating processes. By controlling this balance myosin phosphatase plays a significant role in cell movement cell shape and tension maintenance.

Pathways

Myosin phosphatase is integrated into the RhoA/Rho-kinase signaling pathway which is important for cytoskeletal dynamics and cell adhesion. Within this pathway myosin phosphatase interacts with proteins like Rho-kinase (ROCK) which counter-regulates its activity by inhibiting dephosphorylation. The crosstalk with another protein protein phosphatase 1 is also significant in controlling phosphorylation states and facilitating cellular responses to external stimuli.

Myosin phosphatase is involved in hypertension and heart failure through its action on smooth muscle contraction. Abnormal regulation and activity of this enzyme can lead to unwanted contraction and subsequently increased blood pressure. The protein Rho-kinase is implicated in these conditions as it often modifies the activity of myosin phosphatase. Furthermore deregulation of the associated cellular pathways contributes to cardiac stress and dysfunction highlighting its involvement in heart-related pathology.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Key regulator of protein phosphatase 1C (PPP1C). Mediates binding to myosin. As part of the PPP1C complex, involved in dephosphorylation of PLK1. Capable of inhibiting HIF1AN-dependent suppression of HIF1A activity.
See full target information PPP1R12A

Publications (11)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in molecular biosciences 12:1636882 PubMed40880987

2025

Astrocytes from lamina cribrosa are involved in the autoregulatory function of optic nerve head vessels .

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoxiao Feng,Wenjia Zhang,Tingting Wan,Kangwei Jiao,Liwei Zhang,Changhui Li,Libo Xiao

Lung 203:39 PubMed40047936

2025

FLRT3 Overexpression Attenuates Ischemia-Reperfusion Induced Vascular Hyperpermeability and Lung Injury Through RND3.

Applications

Unspecified application

Species

Unspecified reactive species

Yongmei Cao,Shiyang Sheng,Yong Zhong,Jiawei Shang,Cui Jin,Qin Tan,Feng Ping,Weifeng Huang,Yongchao Liu,Yingchuan Li

Cancer science 112:2739-2752 PubMed33939241

2021

PP1 regulatory subunit NIPP1 regulates transcription of E2F1 target genes following DNA damage.

Applications

Unspecified application

Species

Unspecified reactive species

Shunsuke Hanaki,Makoto Habara,Takahiro Masaki,Keisuke Maeda,Yuki Sato,Makoto Nakanishi,Midori Shimada

Medicine 99:e20060 PubMed32664054

2020

Leukocyte Rho kinase activity and serum cystatin C affect cardiovascular events in acute coronary syndrome.

Applications

Unspecified application

Species

Unspecified reactive species

Li Ma,Wenqin Dai,Yongbo Lin,Zhongyuan Zhang,Yunhong Pan,Hongyan Han,Haizhen Jia,Jun Peng,Jinhe Zhao,Liang Xu

Frontiers in oncology 9:539 PubMed31316912

2019

Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenyu Jia,Jianguo Zhu,Yangjia Zhuo,Ruidong Li,Han Qu,Shibo Wang,Meiyue Wang,Jianming Lu,John M Chater,Renyuan Ma,Ze-Zhen Liu,Zhiduan Cai,Yongding Wu,Funeng Jiang,Huichan He,Wei-De Zhong,Chin-Lee Wu

Pathology, research and practice 215:152464 PubMed31176575

2019

HMGCS2 functions as a tumor suppressor and has a prognostic impact in prostate cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Song Wan,Ming Xi,Hai-Bo Zhao,Wei Hua,Yuan-Ling Liu,Yu-Lin Zhou,Yang-Jia Zhuo,Ze-Zhen Liu,Zhi-Duan Cai,Yue-Ping Wan,Wei-De Zhong

Current molecular medicine 18:100-108 PubMed29974831

2018

Decreased Expression of MYPT1 Contributes to Tumor Angiogenesis and Poor Patient Prognosis in Human Prostate Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Y Liang,Y Zhuo,Z Lin,F Jiang,Q Dai,J Lu,W Dong,X Zhu,Z Han,W Zhong

Experimental and therapeutic medicine 14:2221-2227 PubMed28962146

2017

Expression of MYPT1, CPI-17 and MLC20 in ileum of neonatal mouse NEC model and its significance.

Applications

Unspecified application

Species

Unspecified reactive species

Yinyu Yin,Yiping Li,Jian Pan,Ruze Tang,Jie Zhu,Zhenfang Qin,Xiaobing Xu,Jian Wang

Experimental and therapeutic medicine 14:308-316 PubMed28672931

2017

Resveratrol enhances vascular reactivity in mice following lipopolysaccharide challenge via the RhoA-ROCK-MLCP pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Xu-Qing Wang,Yu-Ping Zhang,Li-Min Zhang,Niu-Niu Feng,Ming-Zhu Zhang,Zi-Gang Zhao,Chun-Yu Niu

Current molecular medicine 13:205-19 PubMed22934846

2012

ROCK1 & 2 perform overlapping and unique roles in angiogenesis and angiosarcoma tumor progression.

Applications

WB

Species

Unspecified reactive species

J Montalvo,C Spencer,A Hackathorn,K Masterjohn,A Perkins,C Doty,A Arumugam,P P Ongusaha,R Lakshmanaswamy,J K Liao,D C Mitchell,B A Bryan
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com